| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.10e-08 | 11 | 188 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.10e-08 | 21 | 188 | 6 | GO:0035613 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | APPBP2 SETX IPO8 ATRX MYO9A DNAH2 RNF213 DHX57 DDX56 CCT4 CHD1L IDE ATP8B2 ORC4 KIF9 DDX25 SHPRH KIF14 MYH15 KIF4B SNRNP200 SMC1B | 8.39e-08 | 614 | 188 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.31e-07 | 14 | 188 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 8.21e-07 | 3 | 188 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATRX DNAH2 RNF213 DHX57 DDX56 CCT4 CHD1L IDE ATP8B2 ORC4 KIF9 DDX25 KIF14 SNRNP200 SMC1B | 1.96e-05 | 441 | 188 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.10e-05 | 18 | 188 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.39e-05 | 37 | 188 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.74e-05 | 38 | 188 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 7.03e-05 | 46 | 188 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.28e-04 | 118 | 188 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | helicase activity | 1.29e-04 | 158 | 188 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.96e-04 | 31 | 188 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 SETX ATRX ERVK-7 ISG20 CHD1L ERVK-10 ERVK-8 SHPRH ERVK-11 | 1.97e-04 | 262 | 188 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.52e-04 | 33 | 188 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.77e-04 | 14 | 188 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.94e-04 | 37 | 188 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 SETX ATRX GATB DHX57 DDX56 ERVK-7 ISG20 CHD1L ERVK-10 DDX25 ERVK-8 SHPRH RARS2 ERVK-11 SNRNP200 | 4.13e-04 | 645 | 188 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.37e-04 | 38 | 188 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.17e-04 | 70 | 188 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 GATB DHX57 DDX56 ERVK-7 ISG20 ERVK-10 DDX25 ERVK-8 RARS2 ERVK-11 SNRNP200 | 6.15e-04 | 417 | 188 | 12 | GO:0140098 |
| GeneOntologyMolecularFunction | insulin binding | 8.65e-04 | 5 | 188 | 2 | GO:0043559 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 9.00e-04 | 79 | 188 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | small GTPase binding | DOCK4 IPO8 PPP6R1 APPL2 GCC2 PRKACA DENND5A RINL TNPO3 SORL1 | 9.62e-04 | 321 | 188 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATRX RNF112 DNAH2 RNF213 DHX57 DDX56 CCT4 CHD1L IDE ATP8B2 ORC4 KIF9 DDX25 KIF14 SNRNP200 SEPTIN12 SMC1B | 1.08e-03 | 775 | 188 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 1.79e-03 | 7 | 188 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 1.82e-03 | 26 | 188 | 3 | GO:0070530 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.84e-03 | 136 | 188 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.13e-03 | 140 | 188 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | GTPase binding | DOCK4 IPO8 PPP6R1 APPL2 GCC2 PRKACA DENND5A RINL TNPO3 SORL1 | 2.25e-03 | 360 | 188 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATRX RNF112 DNAH2 RNF213 DHX57 DDX56 CCT4 CHD1L IDE ATP8B2 ORC4 KIF9 DDX25 KIF14 SNRNP200 SEPTIN12 SMC1B | 2.50e-03 | 839 | 188 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATRX RNF112 DNAH2 RNF213 DHX57 DDX56 CCT4 CHD1L IDE ATP8B2 ORC4 KIF9 DDX25 KIF14 SNRNP200 SEPTIN12 SMC1B | 2.53e-03 | 840 | 188 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATRX RNF112 DNAH2 RNF213 DHX57 DDX56 CCT4 CHD1L IDE ATP8B2 ORC4 KIF9 DDX25 KIF14 SNRNP200 SEPTIN12 SMC1B | 2.53e-03 | 840 | 188 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | microtubule binding | 2.64e-03 | 308 | 188 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.80e-03 | 102 | 188 | 5 | GO:0043178 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 3.04e-03 | 9 | 188 | 2 | GO:0004690 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 3.44e-03 | 206 | 188 | 7 | GO:0140030 | |
| GeneOntologyBiologicalProcess | DNA integration | 7.43e-08 | 13 | 189 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CFAP47 ATRX DNAH2 CDK11A DYSF CCDC39 CEP350 FSIP2 CCDC13 ARHGEF10 GCC2 SYNE2 PDE4DIP CEP135 NINL KIF14 KIF4B CEP295 CTNNB1 PCM1 BBOF1 | 3.02e-06 | 720 | 189 | 21 | GO:0000226 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.12e-05 | 83 | 189 | 7 | GO:0006278 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP47 SEMG1 ATRX DNAH2 CDK11A DYSF CCDC39 CEP350 FSIP2 CCDC13 KIF9 CFAP54 ARHGEF10 GCC2 SYNE2 PDE4DIP CEP135 NINL KIF14 KIF4B CEP295 CTNNB1 PCM1 SEPTIN12 BBOF1 | 1.34e-05 | 1058 | 189 | 25 | GO:0007017 |
| GeneOntologyBiologicalProcess | sexual reproduction | CFAP47 SEMG1 SETX ANGPT2 DPY19L2 ATRX PAQR8 RAD21L1 CCT4 TRIM27 TDRD1 ITPR1 FSIP2 ORC4 LIF CFAP54 IGF1R ANAPC1 AGT PRKACA DDX25 PRKACB OSBP2 CTNNB1 VPS13B SEPTIN12 SMC1B BBOF1 | 2.52e-05 | 1312 | 189 | 28 | GO:0019953 |
| GeneOntologyBiologicalProcess | cilium assembly | CFAP47 ZNF423 TBC1D2 DNAH2 CCDC39 CEP350 FSIP2 CCDC13 CFAP54 SYNE2 CEP135 SNX10 PCM1 BBOF1 | 6.34e-05 | 444 | 189 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | microtubule anchoring | 7.43e-05 | 25 | 189 | 4 | GO:0034453 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 7.62e-05 | 48 | 189 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | CFAP47 SEMG1 ANGPT2 DPY19L2 PAQR8 TDRD1 FSIP2 ORC4 CFAP54 PRKACA DDX25 OSBP2 CTNNB1 VPS13B BBOF1 | 1.09e-04 | 527 | 189 | 15 | GO:0022412 |
| GeneOntologyBiologicalProcess | cilium organization | CFAP47 ZNF423 TBC1D2 DNAH2 CCDC39 CEP350 FSIP2 CCDC13 CFAP54 SYNE2 CEP135 SNX10 PCM1 BBOF1 | 1.32e-04 | 476 | 189 | 14 | GO:0044782 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.43e-04 | 210 | 189 | 9 | GO:0060294 | |
| GeneOntologyBiologicalProcess | germ cell development | CFAP47 SEMG1 ANGPT2 DPY19L2 PAQR8 TDRD1 FSIP2 CFAP54 PRKACA DDX25 OSBP2 CTNNB1 VPS13B BBOF1 | 1.51e-04 | 482 | 189 | 14 | GO:0007281 |
| GeneOntologyBiologicalProcess | spermatid development | CFAP47 SEMG1 DPY19L2 FSIP2 CFAP54 PRKACA DDX25 OSBP2 VPS13B BBOF1 | 1.58e-04 | 262 | 189 | 10 | GO:0007286 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.70e-04 | 215 | 189 | 9 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.70e-04 | 215 | 189 | 9 | GO:0001539 | |
| GeneOntologyBiologicalProcess | spermatid differentiation | CFAP47 SEMG1 DPY19L2 FSIP2 CFAP54 PRKACA DDX25 OSBP2 VPS13B BBOF1 | 2.14e-04 | 272 | 189 | 10 | GO:0048515 |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | CFAP47 SEMG1 SETX ANGPT2 DPY19L2 ATRX KALRN PAQR8 RAD21L1 TRIM27 TDRD1 FSIP2 ORC4 LIF CFAP54 IGF1R AGT PRKACA DDX25 OSBP2 CTNNB1 VPS13B SEPTIN12 BBOF1 | 2.48e-04 | 1194 | 189 | 24 | GO:0048609 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 2.52e-04 | 179 | 189 | 8 | GO:0031023 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 5.87e-05 | 9 | 189 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.14e-04 | 11 | 189 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | t-UTP complex | 2.42e-04 | 3 | 189 | 2 | GO:0034455 | |
| GeneOntologyCellularComponent | nuclear envelope | DPY19L2 IPO8 TRIM27 ITPR1 ITPR3 ADRA1B MACO1 SYNE2 OSBPL7 CTNNB1 TNPO3 PCID2 PCM1 SORL1 | 5.97e-04 | 560 | 189 | 14 | GO:0005635 |
| GeneOntologyCellularComponent | sarcoplasm | 6.00e-04 | 114 | 189 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | centrosome | HK2 CCT4 DYSF CEP350 CCDC13 ARHGEF10 ZBED6 NEK8 PDE4DIP PRKACA CEP135 SNX10 PRKACB NINL CEP295 CTNNB1 PCM1 | 6.48e-04 | 770 | 189 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | HK2 EVC CCT4 DYSF CEP350 CCDC13 ARHGEF10 ZBED6 NEK8 PDE4DIP PRKACA CEP135 SNX10 PRKACB NINL CEP295 CTNNB1 PCM1 BBOF1 | 6.92e-04 | 919 | 189 | 19 | GO:0005815 |
| HumanPheno | Abnormality of the capitate bone | 1.11e-05 | 12 | 65 | 4 | HP:0004262 | |
| HumanPheno | Abnormality of the hamate bone | 1.11e-05 | 12 | 65 | 4 | HP:0004259 | |
| HumanPheno | Capitate-hamate fusion | 1.11e-05 | 12 | 65 | 4 | HP:0001241 | |
| HumanPheno | Neonatal short-limb short stature | 2.20e-05 | 14 | 65 | 4 | HP:0008921 | |
| HumanPheno | Epispadias | 2.71e-05 | 29 | 65 | 5 | HP:0000039 | |
| HumanPheno | Short limb dwarfism | 8.11e-05 | 19 | 65 | 4 | HP:0003505 | |
| HumanPheno | Abnormal incisor morphology | 1.20e-04 | 62 | 65 | 6 | HP:0011063 | |
| HumanPheno | Dwarfism | 1.23e-04 | 21 | 65 | 4 | HP:0001516 | |
| Domain | InsP3_rcpt-bd | 8.95e-07 | 3 | 181 | 3 | IPR000493 | |
| Domain | LRRCT | 1.32e-05 | 32 | 181 | 5 | PF01463 | |
| Domain | RIH_assoc-dom | 1.75e-05 | 6 | 181 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.75e-05 | 6 | 181 | 3 | PF08709 | |
| Domain | RIH_assoc | 1.75e-05 | 6 | 181 | 3 | PF08454 | |
| Domain | RIH_dom | 1.75e-05 | 6 | 181 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.75e-05 | 6 | 181 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.75e-05 | 6 | 181 | 3 | IPR015925 | |
| Domain | - | 1.75e-05 | 6 | 181 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.75e-05 | 6 | 181 | 3 | PF01365 | |
| Domain | LRR_8 | 4.48e-05 | 171 | 181 | 9 | PF13855 | |
| Domain | LRR_TYP | 5.85e-05 | 177 | 181 | 9 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 5.85e-05 | 177 | 181 | 9 | IPR003591 | |
| Domain | Leu-rich_rpt | LRRC8C LRRC57 TLR7 ISLR LRIG3 TLR2 LGR6 CD180 TPBG NLRP13 LRRC74B | 6.99e-05 | 271 | 181 | 11 | IPR001611 |
| Domain | Helicase_C | 8.25e-05 | 107 | 181 | 7 | PF00271 | |
| Domain | HELICc | 8.25e-05 | 107 | 181 | 7 | SM00490 | |
| Domain | Helicase_C | 8.75e-05 | 108 | 181 | 7 | IPR001650 | |
| Domain | L_dom-like | LRRC8C LRRC57 TLR7 ISLR LRIG3 IGF1R TLR2 LGR6 CD180 TPBG NLRP13 LRRC74B | 8.86e-05 | 328 | 181 | 12 | IPR032675 |
| Domain | HELICASE_CTER | 9.27e-05 | 109 | 181 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 9.27e-05 | 109 | 181 | 7 | PS51192 | |
| Domain | DEXDc | 9.27e-05 | 109 | 181 | 7 | SM00487 | |
| Domain | Limbin/Ellis-van_Creveld | 9.34e-05 | 2 | 181 | 2 | IPR026501 | |
| Domain | Helicase_ATP-bd | 9.82e-05 | 110 | 181 | 7 | IPR014001 | |
| Domain | MIR | 1.02e-04 | 10 | 181 | 3 | PF02815 | |
| Domain | MIR_motif | 1.02e-04 | 10 | 181 | 3 | IPR016093 | |
| Domain | MIR | 1.02e-04 | 10 | 181 | 3 | PS50919 | |
| Domain | MIR | 1.02e-04 | 10 | 181 | 3 | SM00472 | |
| Domain | ARM-type_fold | DCAF1 CAB39 IPO8 PPP6R1 HEATR1 ITPR1 ITPR2 PELP1 CEBPZ INTS4 CTNNB1 TNPO3 | 1.21e-04 | 339 | 181 | 12 | IPR016024 |
| Domain | Ion_trans_dom | 1.23e-04 | 114 | 181 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.23e-04 | 114 | 181 | 7 | PF00520 | |
| Domain | LRR | 1.55e-04 | 201 | 181 | 9 | PS51450 | |
| Domain | P-loop_NTPase | SETX ATRX MYO9A RNF112 DNAH2 RNF213 DHX57 DDX56 CHD1L ORC4 KIF9 DDX25 SHPRH KIF14 MYH15 KIF4B SNRNP200 SEPTIN12 SMC1B NLRP13 | 2.19e-04 | 848 | 181 | 20 | IPR027417 |
| Domain | Cys-rich_flank_reg_C | 2.42e-04 | 90 | 181 | 6 | IPR000483 | |
| Domain | LRRCT | 2.42e-04 | 90 | 181 | 6 | SM00082 | |
| Domain | LRR_1 | 2.93e-04 | 219 | 181 | 9 | PF00560 | |
| Domain | - | LRRC8C LRRC57 TLR7 ISLR LRIG3 TLR2 LGR6 CD180 TPBG NLRP13 LRRC74B | 3.07e-04 | 321 | 181 | 11 | 3.80.10.10 |
| Domain | ARM-like | 1.31e-03 | 270 | 181 | 9 | IPR011989 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 9.45e-06 | 5 | 140 | 3 | M49000 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.46e-05 | 32 | 140 | 5 | MM14983 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 1.65e-05 | 113 | 140 | 8 | M16817 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 1.88e-05 | 6 | 140 | 3 | M47960 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 5.06e-05 | 41 | 140 | 5 | M512 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 5.69e-05 | 42 | 140 | 5 | M791 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 6.39e-05 | 43 | 140 | 5 | M39706 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 7.71e-05 | 9 | 140 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.09e-04 | 10 | 140 | 3 | M47661 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.47e-04 | 115 | 140 | 7 | M9387 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.49e-04 | 11 | 140 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.49e-04 | 11 | 140 | 3 | M27466 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.92e-04 | 54 | 140 | 5 | M26911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.55e-04 | 13 | 140 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.55e-04 | 13 | 140 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 2.55e-04 | 13 | 140 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.55e-04 | 13 | 140 | 3 | MM14553 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.42e-04 | 61 | 140 | 5 | MM15071 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 4.88e-04 | 16 | 140 | 3 | M26945 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 6.48e-04 | 70 | 140 | 5 | M3115 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 6.52e-04 | 106 | 140 | 6 | M27077 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 7.38e-04 | 72 | 140 | 5 | MM14631 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 8.27e-04 | 19 | 140 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.27e-04 | 19 | 140 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 8.27e-04 | 19 | 140 | 3 | M47733 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 9.30e-04 | 44 | 140 | 4 | M39845 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 9.60e-04 | 5 | 140 | 2 | M26988 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION | 9.60e-04 | 5 | 140 | 2 | M49011 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 9.66e-04 | 20 | 140 | 3 | M47688 | |
| Pubmed | DCAF1 IPO8 NOP56 ATRX MBOAT7 TRPM7 GATB PPP6R1 HEATR1 TRIM27 ITPR1 ITPR2 ITPR3 SLC12A2 SACS ARHGEF10 CEBPZ MACO1 UTP4 SYNE2 PRKACA PRKACB MRPS9 CTNNB1 RPP25L SNRNP200 IMMT RPL7A VPS13B PCM1 GOLGB1 | 1.71e-10 | 1487 | 191 | 31 | 33957083 | |
| Pubmed | HK2 IPO8 NOP56 RBBP7 PACSIN3 RNF213 DHX57 DDX56 CCT4 PPP6R1 HEATR1 TRIM27 ITPR1 ITPR2 ITPR3 PELP1 CEBPZ MACO1 SYNE2 MRPS9 KIF14 RARS2 CTNNB1 SLC39A14 SNRNP200 TNPO3 PCM1 CCDC93 | 6.63e-09 | 1440 | 191 | 28 | 30833792 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | APPBP2 IPO8 HEATR1 IDE CEP350 CEBPZ GCC2 MACO1 PDE4DIP PRKACA CEP135 MRPS9 NINL INTS4 SLC39A14 TNPO3 PCM1 GOLGB1 CCDC93 | 4.25e-08 | 754 | 191 | 19 | 33060197 |
| Pubmed | SETX MAN2A1 ATRX MBOAT7 RBBP7 PACSIN3 CDK11A DHX57 DDX56 CCT4 ICE1 HEATR1 TRIM27 ORC4 APPL2 SLC12A2 CEBPZ ANAPC1 ZBED6 MACO1 UTP4 BRD9 PRKACA KIF14 IMMT PCID2 GOLGB1 | 5.94e-08 | 1497 | 191 | 27 | 31527615 | |
| Pubmed | 1.09e-07 | 9 | 191 | 4 | 37903214 | ||
| Pubmed | MBOAT7 TRPM7 APBB2 DHX57 ITPR1 ITPR2 ITPR3 LRIG3 APPL2 SLC12A2 MACO1 SYNE2 IMMT VPS13B GOLGB1 | 1.47e-07 | 504 | 191 | 15 | 34432599 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 17437169 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 18547250 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 36350267 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 11413485 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 26009177 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 1.63e-07 | 3 | 191 | 3 | 1693919 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 31979185 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 9808793 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 18194433 | ||
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 1.63e-07 | 3 | 191 | 3 | 18241669 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 19068129 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 17327232 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 10874040 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 20395455 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 23955339 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 1.63e-07 | 3 | 191 | 3 | 24904548 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 1.63e-07 | 3 | 191 | 3 | 9858485 | |
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 1.63e-07 | 3 | 191 | 3 | 27777977 | |
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 1.63e-07 | 3 | 191 | 3 | 17581770 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 16014380 | ||
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 1.63e-07 | 3 | 191 | 3 | 23983250 | |
| Pubmed | 1.63e-07 | 3 | 191 | 3 | 20427533 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 SETX ATRX MYO9A RBBP7 CDK11A PPP6R1 RUFY1 ANAPC1 MACO1 UTP4 KIF14 CTNNB1 PCM1 GOLGB1 SORL1 | 1.88e-07 | 588 | 191 | 16 | 38580884 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HK2 IPO8 NOP56 TRPM7 GATB RNF213 DHX57 DDX56 CCT4 HEATR1 IDE ITPR1 ITPR2 ITPR3 SLC12A2 MACO1 UTP4 SYNE2 PRKACA MRPS9 RARS2 SLC39A14 MTO1 IMMT VPS13B GOLGB1 | 2.19e-07 | 1496 | 191 | 26 | 32877691 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOP56 PACSIN3 DDX56 CCT4 HEATR1 ITPR2 ITPR3 CEP350 SLC12A2 PELP1 SACS CEBPZ UTP4 SYNE2 KIF14 CTNNB1 SNRNP200 IMMT RPL7A PCM1 GOLGB1 | 2.54e-07 | 1024 | 191 | 21 | 24711643 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 JCAD SETX TRPM7 MYO9A RBBP7 CEP350 FSIP2 IGF1R SLC12A2 ARHGEF10 IKBKE SYNE2 OTUD7A KIF14 NHS TNPO3 PCM1 GOLGB1 | 3.27e-07 | 861 | 191 | 19 | 36931259 |
| Pubmed | JCAD CTNNAL1 RNF213 CCT4 PPP6R1 IDE PPEF1 ITPR1 ITPR2 ITPR3 CEP350 SLC12A2 CEBPZ MACO1 SYNE2 PRKACA CEP135 INTS4 KIF14 NHS EIF2AK4 | 3.76e-07 | 1049 | 191 | 21 | 27880917 | |
| Pubmed | NOP56 ATRX PCDHGB7 DNAH2 GATB DHX57 CCT4 ZBTB41 HEATR1 PHEX SACS CEBPZ SYNE2 PRKACA PRKACB MRPS9 MYH15 CEP295 EIF2AK4 ITIH6 IMMT RPL7A PCID2 GOLGB1 BBOF1 | 4.01e-07 | 1442 | 191 | 25 | 35575683 | |
| Pubmed | DCAF1 DPY19L2 RUFY1 ITPR2 ITPR3 RNF20 CEP135 RARS2 IMMT PCM1 GOLGB1 | 5.78e-07 | 285 | 191 | 11 | 32838362 | |
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 25215520 | ||
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 11163362 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.50e-07 | 4 | 191 | 3 | 10469592 | |
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 6.50e-07 | 4 | 191 | 3 | 21424589 | |
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 28615414 | ||
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 10828023 | ||
| Pubmed | 6.50e-07 | 4 | 191 | 3 | 28419336 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 6.50e-07 | 4 | 191 | 3 | 35494252 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 LRRC8C APPBP2 SETX RNF112 TBC1D2 DNAH2 RNF213 ZBTB41 ICE1 PPP6R1 PARVG CCDC39 ITPR2 CEP295 C6 SNRNP200 | 7.55e-07 | 736 | 191 | 17 | 29676528 |
| Pubmed | PPP1R21 JCAD IPO8 NOP56 DNAH2 HEATR1 TRIM27 CCDC39 ITPR1 SYNE2 SHPRH KIF14 ZRANB1 SNRNP200 IMMT PCID2 GOLGB1 | 1.05e-06 | 754 | 191 | 17 | 35906200 | |
| Pubmed | SETX TRPM7 APBB2 RNF213 CCT4 RUFY1 CEP350 LRIG3 SLC12A2 ZBED6 GCC2 MRPS9 SLC39A14 SNRNP200 RPL7A PCM1 GOLGB1 | 1.58e-06 | 777 | 191 | 17 | 35844135 | |
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 1.62e-06 | 5 | 191 | 3 | 21568942 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 SEMG1 CTNNAL1 IPO8 RBBP7 CCT4 PPP6R1 HEATR1 IDE PPEF1 ITPR3 MACO1 CORO7 SNRNP200 IMMT TNPO3 RPL7A PCM1 SORL1 | 2.04e-06 | 974 | 191 | 19 | 28675297 |
| Pubmed | PPP1R21 LRRC8C ACAP1 HK2 MAN2A1 NOP56 MBOAT7 RNF213 DDX56 HEATR1 ITPR1 ITPR2 ITPR3 CEP350 PELP1 GCC2 KIF14 CORO7 IMMT PCM1 GOLGB1 | 2.08e-06 | 1168 | 191 | 21 | 19946888 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.22e-06 | 6 | 191 | 3 | 25966694 | |
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 20519450 | ||
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 3.22e-06 | 6 | 191 | 3 | 21762810 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.22e-06 | 6 | 191 | 3 | 16844763 | |
| Pubmed | RBBP7 DHX57 DDX56 HEATR1 ITPR3 PELP1 CEBPZ ANAPC1 UTP4 SYNE2 KIF14 SNRNP200 IMMT RPL7A PCM1 | 3.70e-06 | 653 | 191 | 15 | 22586326 | |
| Pubmed | DCAF1 SEMG1 RBBP7 RNF213 DDX56 PPP6R1 TRIM27 LRIG3 MCTP1 ZFHX4 ANAPC1 BRD9 RARS2 CEP295 SPOP TRAF3IP3 MTO1 PCID2 PCM1 SORL1 | 3.88e-06 | 1116 | 191 | 20 | 31753913 | |
| Pubmed | DCAF1 RMND5B CDK11A PPP6R1 ZFHX4 PELP1 ANAPC1 MRPS9 CTNNB1 TNPO3 | 4.05e-06 | 282 | 191 | 10 | 23667531 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 JCAD IPO8 CCT4 RUFY1 MSTO1 CEP350 MACO1 CEP135 PRKACB NINL KIF14 CEP295 RPP25L RINL PCID2 PCM1 | 5.45e-06 | 853 | 191 | 17 | 28718761 |
| Pubmed | 5.61e-06 | 7 | 191 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 5.61e-06 | 7 | 191 | 3 | 22495310 | |
| Pubmed | 5.61e-06 | 7 | 191 | 3 | 18281465 | ||
| Pubmed | 5.97e-06 | 22 | 191 | 4 | 11696558 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | CAB39 LRRC8C MBOAT7 TRPM7 APBB2 ITPR1 ITPR2 ITPR3 SLC12A2 MACO1 SYNE2 GOLGB1 | 1.21e-05 | 468 | 191 | 12 | 31056421 |
| Pubmed | Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice. | 1.34e-05 | 9 | 191 | 3 | 18492657 | |
| Pubmed | 1.34e-05 | 9 | 191 | 3 | 25737585 | ||
| Pubmed | 1.40e-05 | 27 | 191 | 4 | 18685082 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | SEMG1 NOP56 MYO9A PPFIBP2 DHX57 DDX56 CCT4 HEATR1 IDE ITPR2 MACO1 AGT MRPS9 KIF14 CTNNB1 | 1.43e-05 | 732 | 191 | 15 | 34732716 |
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 1.44e-05 | 142 | 191 | 7 | 11812828 | |
| Pubmed | RNF213 ICE1 ITPR2 CEP350 SLC12A2 ARHGEF10 CEBPZ ANAPC1 MACO1 CEP135 KIF14 CEP295 CTNNB1 CORO7 PCM1 | 1.46e-05 | 733 | 191 | 15 | 34672954 | |
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 1.57e-05 | 57 | 191 | 5 | 16462731 | |
| Pubmed | 1.72e-05 | 146 | 191 | 7 | 21399614 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.72e-05 | 202 | 191 | 8 | 33005030 | |
| Pubmed | MBOAT7 TRPM7 RUFY1 ITPR1 ITPR3 SLC12A2 GCC2 MACO1 SYNE2 SLC39A14 VPS13B PCID2 PCM1 | 1.74e-05 | 568 | 191 | 13 | 37774976 | |
| Pubmed | RBBP7 CCT4 DSN1 ORC4 PELP1 CEBPZ MRPS9 INTS4 OSBP2 CTNNB1 RPL7A | 1.90e-05 | 411 | 191 | 11 | 36652389 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 2.05e-05 | 150 | 191 | 7 | 30154076 | |
| Pubmed | 2.28e-05 | 210 | 191 | 8 | 16565220 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 2.60e-05 | 11 | 191 | 3 | 27514653 | |
| Pubmed | 2.89e-05 | 107 | 191 | 6 | 28005267 | ||
| Pubmed | JCAD ATRX KALRN TRPM7 ZNF423 APBB2 ZNF214 MSTO1 CEP350 CCDC13 KANSL2 APPL2 SACS ARHGEF10 PDE4DIP MRPS9 MGAT5B SNRNP200 IMMT PCM1 | 2.97e-05 | 1285 | 191 | 20 | 35914814 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 28925399 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 11694504 | ||
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 3.00e-05 | 2 | 191 | 2 | 3023318 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 15890645 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 3.00e-05 | 2 | 191 | 2 | 8081734 | |
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 3.00e-05 | 2 | 191 | 2 | 23582047 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 26580685 | ||
| Pubmed | ORP4L couples IP3 to ITPR1 in control of endoplasmic reticulum calcium release. | 3.00e-05 | 2 | 191 | 2 | 31648575 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 19810119 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 14993280 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 36152045 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 36370035 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 2833513 | ||
| Pubmed | Toll-like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis. | 3.00e-05 | 2 | 191 | 2 | 31211901 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 16621795 | ||
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 18505929 | ||
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 3.00e-05 | 2 | 191 | 2 | 17496801 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 3.00e-05 | 2 | 191 | 2 | 8663526 | |
| Pubmed | 3.00e-05 | 2 | 191 | 2 | 31040297 | ||
| Pubmed | Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis-van Creveld syndrome patients. | 3.00e-05 | 2 | 191 | 2 | 17024374 | |
| Interaction | TMT1A interactions | LRRC57 MBOAT7 TRPM7 APBB2 CCDC168 ITPR1 ITPR2 ITPR3 LRIG3 SLC12A2 GCC2 MACO1 SYNE2 ZRANB1 VPS13B GOLGB1 | 2.58e-07 | 359 | 187 | 16 | int:TMT1A |
| Interaction | MAGEA9 interactions | MYO9A GATB ITPR1 ITPR2 ITPR3 ZFHX4 SHPRH KIF14 RARS2 EIF2AK4 MTO1 | 4.05e-06 | 208 | 187 | 11 | int:MAGEA9 |
| Interaction | COIL interactions | KCNE3 NOP56 KALRN UVSSA CDK11A DDX56 CCT4 ICE1 ZNF780A CEBPZ UTP4 KIF14 KLHL8 ZRANB1 SNRNP200 TNPO3 RPL7A PCID2 | 4.13e-06 | 552 | 187 | 18 | int:COIL |
| Interaction | FBXO42 interactions | DOCK4 MYO9A CCT4 PPP6R1 RUFY1 ANAPC1 MACO1 KIF14 CTNNB1 RPL7A PCM1 GOLGB1 | 5.74e-06 | 259 | 187 | 12 | int:FBXO42 |
| Interaction | ELOVL5 interactions | MBOAT7 TRPM7 ITPR1 ITPR2 ITPR3 LRIG3 SLC12A2 GCC2 MACO1 SYNE2 SLC39A14 ZRANB1 VPS13B GOLGB1 | 8.14e-06 | 364 | 187 | 14 | int:ELOVL5 |
| Interaction | SEPTIN10 interactions | 8.15e-06 | 144 | 187 | 9 | int:SEPTIN10 | |
| Interaction | RPGRIP1L interactions | PPP1R21 IPO8 DDX56 TRIM27 CEP350 UTP4 CEP135 NINL KIF14 RPP25L PCM1 | 8.56e-06 | 225 | 187 | 11 | int:RPGRIP1L |
| Interaction | ATG16L1 interactions | IPO8 RBBP7 APBB2 DDX56 CCDC168 PPP6R1 TRIM27 RUFY1 ITPR1 ITPR2 ITPR3 CEP350 APPL2 GCC2 TLR2 BRD9 MRPS9 KIF14 TRAF3IP3 CORO7 NNMT ZRANB1 IMMT RPL7A PCID2 PCM1 GOLGB1 | 9.70e-06 | 1161 | 187 | 27 | int:ATG16L1 |
| Interaction | NUP155 interactions | EVC2 MBOAT7 TRPM7 ITPR1 ITPR2 ITPR3 IGF1R GCC2 MACO1 SYNE2 CEP135 KIF14 ZRANB1 RPL7A VPS13B GOLGB1 | 1.02e-05 | 477 | 187 | 16 | int:NUP155 |
| Interaction | DNAJC25 interactions | NOP56 MBOAT7 PPP6R1 ITPR1 ITPR2 ITPR3 SLC12A2 MACO1 SYNE2 IMMT RPL7A VPS13B | 1.45e-05 | 284 | 187 | 12 | int:DNAJC25 |
| Interaction | EMD interactions | EVC2 MBOAT7 TRPM7 UVSSA PPEF1 RUFY1 ITPR1 ITPR2 ITPR3 KIF9 IGF1R SLC12A2 MACO1 SYNE2 PRKACA CEP135 TRAF3IP3 CTNNB1 ZRANB1 SNRNP200 VPS13B | 1.46e-05 | 789 | 187 | 21 | int:EMD |
| Interaction | HSD3B7 interactions | APPBP2 LRRC57 MBOAT7 TRPM7 ITPR1 ITPR2 ITPR3 SLC12A2 GCC2 MACO1 SYNE2 SLC39A14 MGAT5B GOLGB1 | 1.57e-05 | 386 | 187 | 14 | int:HSD3B7 |
| Interaction | PCNT interactions | IPO8 KALRN RBBP7 CEP350 UTP4 PRKACA CEP135 NINL KIF14 ZRANB1 PCM1 | 1.63e-05 | 241 | 187 | 11 | int:PCNT |
| Interaction | COMTD1 interactions | CAB39 SETX IPO8 PPP6R1 HEATR1 MSTO1 INTS4 SLC39A14 ZRANB1 TNPO3 | 1.82e-05 | 200 | 187 | 10 | int:COMTD1 |
| Interaction | EFNB1 interactions | SETX IPO8 RNF213 HEATR1 MSTO1 KRBA1 SLC12A2 SACS INTS4 KIF14 TNPO3 | 2.75e-05 | 255 | 187 | 11 | int:EFNB1 |
| Interaction | GJA1 interactions | CTNNAL1 KALRN TRPM7 APBB2 ITPR2 ITPR3 LRIG3 IGF1R SLC12A2 ARHGEF10 GCC2 MACO1 SYNE2 CTNNB1 SLC39A14 VPS13B GOLGB1 | 3.24e-05 | 583 | 187 | 17 | int:GJA1 |
| Interaction | NDC80 interactions | TRPM7 ICE1 DSN1 CEP350 GCC2 SYNE2 CEP135 KIF14 NHS CEP295 ZRANB1 PCM1 | 3.66e-05 | 312 | 187 | 12 | int:NDC80 |
| Interaction | ANPEP interactions | 3.69e-05 | 174 | 187 | 9 | int:ANPEP | |
| Interaction | CCDC8 interactions | KCNE3 NOP56 RBBP7 PACSIN3 HEATR1 ITPR2 ITPR3 CEP350 SLC12A2 SACS PRKACA CTNNB1 ZRANB1 SNRNP200 IMMT RPL7A PCM1 GOLGB1 | 4.18e-05 | 656 | 187 | 18 | int:CCDC8 |
| Interaction | B3GAT1 interactions | MBOAT7 TRPM7 APBB2 ITPR1 ITPR2 ITPR3 SLC12A2 GCC2 MACO1 SYNE2 SLC39A14 VPS13B GOLGB1 | 5.35e-05 | 377 | 187 | 13 | int:B3GAT1 |
| Interaction | NOLC1 interactions | NOP56 CDK11A RNF213 DDX56 PELP1 CEBPZ UTP4 BRD9 PRKACA KIF14 ZRANB1 RPL7A | 5.43e-05 | 325 | 187 | 12 | int:NOLC1 |
| Interaction | RAC2 interactions | CTNNAL1 MBOAT7 TRPM7 DDX56 RUFY1 ITPR1 ITPR3 SLC12A2 MACO1 SYNE2 PRKACB KIF14 NHS CTNNB1 SLC39A14 IMMT VPS13B GOLGB1 | 5.92e-05 | 674 | 187 | 18 | int:RAC2 |
| Interaction | RND2 interactions | MBOAT7 TRPM7 DDX56 RUFY1 ITPR1 SLC12A2 MACO1 SYNE2 KIF14 CTNNB1 SLC39A14 IMMT VPS13B GOLGB1 | 6.56e-05 | 440 | 187 | 14 | int:RND2 |
| Interaction | RASEF interactions | 7.80e-05 | 25 | 187 | 4 | int:RASEF | |
| Interaction | SIGLECL1 interactions | 8.93e-05 | 113 | 187 | 7 | int:SIGLECL1 | |
| Interaction | PKD2L2 interactions | 1.23e-04 | 11 | 187 | 3 | int:PKD2L2 | |
| Interaction | RAB9A interactions | KCNE3 MBOAT7 TRPM7 APBB2 RUFY1 ITPR2 ITPR3 SLC12A2 GCC2 MACO1 SYNE2 SLC39A14 IMMT VPS13B GOLGB1 MCOLN2 | 1.43e-04 | 595 | 187 | 16 | int:RAB9A |
| Interaction | USP36 interactions | DOCK4 NOP56 DHX57 DDX56 CCT4 HEATR1 CEP350 PELP1 CEBPZ UTP4 SHPRH KIF14 CTNNB1 ZRANB1 IMMT RPL7A | 1.54e-04 | 599 | 187 | 16 | int:USP36 |
| Interaction | TAFA4 interactions | 1.56e-04 | 55 | 187 | 5 | int:TAFA4 | |
| Interaction | MCM10 interactions | 1.60e-04 | 124 | 187 | 7 | int:MCM10 | |
| Interaction | CCDC85C interactions | 1.68e-04 | 125 | 187 | 7 | int:CCDC85C | |
| Interaction | NEK2 interactions | 1.85e-04 | 127 | 187 | 7 | int:NEK2 | |
| Interaction | LAMP3 interactions | MBOAT7 TRPM7 RNF213 HEATR1 ITPR2 ITPR3 APPL2 SLC12A2 GCC2 MACO1 SYNE2 INTS4 SLC39A14 GOLGB1 | 1.86e-04 | 486 | 187 | 14 | int:LAMP3 |
| Interaction | ERGIC1 interactions | MBOAT7 TRPM7 ITPR2 ITPR3 SLC12A2 MACO1 SYNE2 KIF14 SLC39A14 GOLGB1 | 1.86e-04 | 264 | 187 | 10 | int:ERGIC1 |
| Interaction | USO1 interactions | DNAH2 CCDC168 RUFY1 PDE4DIP PRKACA SPOP CTNNB1 ZRANB1 GOLGB1 | 1.87e-04 | 215 | 187 | 9 | int:USO1 |
| Interaction | DISC1 interactions | NOP56 KALRN PPP6R1 TRIM27 CEP350 CCDC13 KIF9 PDE4DIP RNF20 ZRANB1 IMMT PCM1 SORL1 | 1.94e-04 | 429 | 187 | 13 | int:DISC1 |
| Interaction | SIRT7 interactions | DCAF1 NOP56 RBBP7 DHX57 DDX56 HEATR1 ITPR3 PELP1 CEBPZ ANAPC1 UTP4 SYNE2 KIF14 ZRANB1 SNRNP200 IMMT RPL7A PCM1 | 2.03e-04 | 744 | 187 | 18 | int:SIRT7 |
| Interaction | TACSTD2 interactions | 2.04e-04 | 129 | 187 | 7 | int:TACSTD2 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 2.85e-07 | 3 | 120 | 3 | 297 | |
| GeneFamily | Basic leucine zipper proteins|CCAAT/enhancer binding proteins | 6.44e-04 | 6 | 120 | 2 | 1165 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | VWA3A EVC2 SETX UVSSA MSTO1 LURAP1L SLC12A2 SHPRH RPP25L VPS13B | 1.70e-06 | 199 | 186 | 10 | M7530 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 APPBP2 SETX MAN2A1 ATRX APBB2 ITPR1 CEP350 IGF1R SACS ARHGEF10 GCC2 SYNE2 CEP135 PRKACB KIF14 SPOP DENND5A VPS13B CCDC93 | 3.26e-06 | 856 | 186 | 20 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CTNNAL1 SETX MYO9A ITPR1 ITPR2 CEP350 SACS CEBPZ GCC2 SYNE2 RNF20 SNX10 KIF14 RORA PCM1 GOLGB1 SORL1 | 4.83e-06 | 656 | 186 | 17 | M18979 |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | PPP1R21 DHX57 GCC2 SYNE2 PDE4DIP SPOP TRAF3IP3 RPP25L MGAT5B | 1.38e-05 | 200 | 186 | 9 | M4768 |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_DN | 1.38e-05 | 200 | 186 | 9 | M8763 | |
| Coexpression | GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP | 2.92e-05 | 169 | 186 | 8 | M6700 | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | DOCK4 TBC1D2 DYSF LIF MCTP1 TLR2 PLAU TRAF3IP3 DENND5A SORL1 | 5.57e-09 | 183 | 186 | 10 | da43827952e6fdee2ce94648c316182f272b321c |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 6.86e-09 | 187 | 186 | 10 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.18e-08 | 198 | 186 | 10 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BNC2 ATRX CDK11A RNF213 SYNE2 RORA SNRNP200 VPS13B PCM1 GOLGB1 | 1.24e-08 | 199 | 186 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | MAN2A1 DPY19L2 KALRN RNF213 HEATR1 ZBED6 OSBP2 SLC39A14 PCM1 | 5.82e-08 | 176 | 186 | 9 | 3de0c7d77210049e5616db21eed1490a17a5ec2d |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-08 | 183 | 186 | 9 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-07 | 189 | 186 | 9 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-07 | 189 | 186 | 9 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.40e-07 | 195 | 186 | 9 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.52e-07 | 197 | 186 | 9 | 2e9677b4b9a7c88db16416e5f114a2031ec3bc24 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-07 | 197 | 186 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 1.52e-07 | 197 | 186 | 9 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.66e-07 | 199 | 186 | 9 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-07 | 160 | 186 | 8 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-07 | 160 | 186 | 8 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.80e-07 | 169 | 186 | 8 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 6.07e-07 | 170 | 186 | 8 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-07 | 177 | 186 | 8 | baf78a8dad55f124f56585f88b10b58c0269680f | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.02e-06 | 182 | 186 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.02e-06 | 182 | 186 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 187 | 186 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.30e-06 | 188 | 186 | 8 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.30e-06 | 188 | 186 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.58e-06 | 193 | 186 | 8 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 1.70e-06 | 195 | 186 | 8 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 195 | 186 | 8 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.84e-06 | 197 | 186 | 8 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.84e-06 | 197 | 186 | 8 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.84e-06 | 197 | 186 | 8 | 4c9919914079e76b1d2220b249e0d0b0d9bf4bc0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-06 | 197 | 186 | 8 | 59b1fb93a39dcf8c994d2b7dc2906dae74c57527 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.84e-06 | 197 | 186 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_CTL|Leuk-UTI / Disease, condition lineage and cell class | 1.98e-06 | 199 | 186 | 8 | b2609f9d716fdd04f35f0da7f8995d28d7df431d | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.98e-06 | 199 | 186 | 8 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 2.06e-06 | 200 | 186 | 8 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 200 | 186 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 200 | 186 | 8 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_CTL|Leuk-UTI / Disease, Lineage and Cell Type | 3.92e-06 | 154 | 186 | 7 | 170a421fd69dba2929568c72e983ae9cfaf2aabc | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.26e-06 | 161 | 186 | 7 | d0482666479530cd2fd0d229cbb59a1d79839477 | |
| ToppCell | Mild-Lymphoid-NK-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 5.47e-06 | 162 | 186 | 7 | bd218e41b2eadc3bba4c7ac3e34a014f6ad8b1bf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.47e-06 | 162 | 186 | 7 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-06 | 162 | 186 | 7 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.17e-06 | 165 | 186 | 7 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.17e-06 | 165 | 186 | 7 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.42e-06 | 166 | 186 | 7 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.68e-06 | 167 | 186 | 7 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.22e-06 | 169 | 186 | 7 | e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.22e-06 | 169 | 186 | 7 | d375a1df1ecc938f66bad92e54b8cda26ca9c472 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.22e-06 | 169 | 186 | 7 | 58f805c0be507bd5fadc9ea3555032daabbc8ab8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.22e-06 | 169 | 186 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.10e-06 | 172 | 186 | 7 | 9497948bbe53fb88c6ff6b347f743d456da587e5 | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 8.10e-06 | 172 | 186 | 7 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.42e-06 | 173 | 186 | 7 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.74e-06 | 174 | 186 | 7 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 8.74e-06 | 174 | 186 | 7 | d2ea5b55bf03a8013816d073896208f311c3e544 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 9.77e-06 | 177 | 186 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.01e-05 | 178 | 186 | 7 | 90dedb3cef9b01907b9f8eec64218d6d2072be1f | |
| ToppCell | Healthy_Control-Lymphoid-NK-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.01e-05 | 178 | 186 | 7 | 71e99f143009b2d29cb47b96393b58b514c8cfc6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.01e-05 | 178 | 186 | 7 | d6312286bf6cc5b107ccd7adb583d9667d4e1d21 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 181 | 186 | 7 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 182 | 186 | 7 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 183 | 186 | 7 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | Healthy_Control-Lymphoid-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.21e-05 | 183 | 186 | 7 | b41b1f32022c8632a638cf1c5523c9a24176f568 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-05 | 184 | 186 | 7 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.26e-05 | 184 | 186 | 7 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.26e-05 | 184 | 186 | 7 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.30e-05 | 185 | 186 | 7 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 185 | 186 | 7 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.30e-05 | 185 | 186 | 7 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.30e-05 | 185 | 186 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.30e-05 | 185 | 186 | 7 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-05 | 186 | 186 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 186 | 186 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 186 | 186 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.35e-05 | 186 | 186 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 1.35e-05 | 186 | 186 | 7 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 188 | 186 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.49e-05 | 189 | 186 | 7 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.49e-05 | 189 | 186 | 7 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.49e-05 | 189 | 186 | 7 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-05 | 189 | 186 | 7 | ebb5e069fdca7cf8ffac16a57572e92d2593c86a | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.49e-05 | 189 | 186 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-05 | 189 | 186 | 7 | a59e4eaff430a443f9fa7edabe64e66a15b6bffb | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.55e-05 | 190 | 186 | 7 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-05 | 190 | 186 | 7 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-05 | 190 | 186 | 7 | 4b4fe93061c87605dddf5bec94fa07c749c722aa | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-05 | 190 | 186 | 7 | 5c8aa310886c64ee5dce4ba46a3dd178da549529 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 1.55e-05 | 190 | 186 | 7 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.55e-05 | 190 | 186 | 7 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.55e-05 | 190 | 186 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 191 | 186 | 7 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-05 | 191 | 186 | 7 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-05 | 191 | 186 | 7 | 9f0d956e9a14b1cd2c20a52639c6b22c349b377e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.60e-05 | 191 | 186 | 7 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | Healthy_Control-Lymphoid-T-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.65e-05 | 192 | 186 | 7 | 36b6ea21b0b1342f2dcac4dcaf359b6c772203f7 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 192 | 186 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.26e-07 | 49 | 101 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of RFC4 | 8.44e-05 | 151 | 101 | 8 | MORF_RFC4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.00e-04 | 50 | 101 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1 | |
| Computational | Neighborhood of BUB1B | 3.76e-04 | 66 | 101 | 5 | MORF_BUB1B | |
| Drug | Magnetite Nanoparticles | LRRC8C ACAP1 ANGPT2 ATRX TRPM7 PPFIBP2 RNF213 TLR7 ISG20 IDE ITPR1 ITPR2 TGFBI LIF IGF1R ZFHX4 SACS IKBKE ANAPC1 AGT TLR2 PDE4DIP DDX25 PAPPA PLAGL2 PLAU NNMT MGAT5B ZRANB1 ADAT1 PCM1 TPBG MCOLN2 SORL1 | 2.11e-09 | 1310 | 187 | 34 | ctd:D058185 |
| Drug | Succimer | LRRC8C ACAP1 ANGPT2 ATRX TRPM7 PPFIBP2 RNF213 TLR7 ISG20 IDE ITPR1 ITPR2 LIF IGF1R ZFHX4 SACS IKBKE ANAPC1 AGT PDE4DIP PAPPA PLAGL2 PLAU NNMT MGAT5B ZRANB1 ADAT1 PCM1 TPBG MCOLN2 SORL1 | 4.40e-08 | 1264 | 187 | 31 | ctd:D004113 |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A | 5.76e-07 | 192 | 187 | 11 | 5575_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A | DCAF1 MBOAT7 PPFIBP2 DNAH2 UBOX5 LIF IKBKE PLAU TRAF3IP3 VPS13B | 5.36e-06 | 196 | 187 | 10 | 5000_UP |
| Drug | geldanamycin | CAB39 SETX IPO8 ATRX HEATR1 APPL2 ZFHX4 ZBED6 PDE4DIP PAPPA PLAU CTNNB1 PCM1 | 1.30e-05 | 371 | 187 | 13 | ctd:C001277 |
| Disease | Ellis-van Creveld syndrome | 3.78e-05 | 2 | 182 | 2 | cv:C0013903 | |
| Disease | fibrolamellar carcinoma (is_implicated_in) | 3.78e-05 | 2 | 182 | 2 | DOID:5015 (is_implicated_in) | |
| Disease | ELLIS-VAN CREVELD SYNDROME | 3.78e-05 | 2 | 182 | 2 | 225500 | |
| Disease | Ellis-Van Creveld syndrome (implicated_via_orthology) | 3.78e-05 | 2 | 182 | 2 | DOID:12714 (implicated_via_orthology) | |
| Disease | Weyers acrofacial dysostosis (is_implicated_in) | 3.78e-05 | 2 | 182 | 2 | DOID:0111571 (is_implicated_in) | |
| Disease | Hypoxic Brain Damage | 3.78e-05 | 2 | 182 | 2 | C1140716 | |
| Disease | WEYERS ACROFACIAL DYSOSTOSIS | 3.78e-05 | 2 | 182 | 2 | 193530 | |
| Disease | Curry-Hall syndrome | 3.78e-05 | 2 | 182 | 2 | cv:C0457013 | |
| Disease | Anoxic Encephalopathy | 3.78e-05 | 2 | 182 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 3.78e-05 | 2 | 182 | 2 | C1527348 | |
| Disease | Anoxia of brain | 3.78e-05 | 2 | 182 | 2 | C0995195 | |
| Disease | Weyers acrofacial dysostosis | 3.78e-05 | 2 | 182 | 2 | C0457013 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 4.87e-05 | 12 | 182 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Myocardial Preinfarction Syndrome | 1.13e-04 | 3 | 182 | 2 | C0086666 | |
| Disease | Ellis-Van Creveld syndrome (is_implicated_in) | 1.13e-04 | 3 | 182 | 2 | DOID:12714 (is_implicated_in) | |
| Disease | Angina, Unstable | 1.13e-04 | 3 | 182 | 2 | C0002965 | |
| Disease | Anuria | 1.13e-04 | 3 | 182 | 2 | C0003460 | |
| Disease | Colorectal Carcinoma | PCSK2 ACAP1 EVC2 KALRN TRPM7 ISLR SACS TLR2 TRAF3IP3 LGR6 CTNNB1 SNRNP200 CCDC93 SORL1 | 1.25e-04 | 702 | 182 | 14 | C0009402 |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.18e-04 | 195 | 182 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Ellis-Van Creveld Syndrome | 2.25e-04 | 4 | 182 | 2 | C0013903 | |
| Disease | Adrenal Cortical Adenoma | 2.25e-04 | 4 | 182 | 2 | C0206667 | |
| Disease | epilepsy (implicated_via_orthology) | 5.41e-04 | 163 | 182 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Ciliopathies | 6.13e-04 | 110 | 182 | 5 | C4277690 | |
| Disease | Immune System Diseases | 7.79e-04 | 7 | 182 | 2 | C0021053 | |
| Disease | NEPHRONOPHTHISIS 2 | 1.03e-03 | 8 | 182 | 2 | C1865872 | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.32e-03 | 9 | 182 | 2 | DOID:988 (is_implicated_in) | |
| Disease | urinary bladder cancer (implicated_via_orthology) | 1.32e-03 | 9 | 182 | 2 | DOID:11054 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | PPFIBP2 TBC1D2 ITPR1 APPL2 SLC12A2 PRKACB INTS4 PLAU SPOP CTNNB1 TPBG | 1.62e-03 | 616 | 182 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | PPFIBP2 TBC1D2 ITPR1 APPL2 SLC12A2 PRKACB INTS4 PLAU SPOP CTNNB1 TPBG | 1.62e-03 | 616 | 182 | 11 | C0376358 |
| Disease | post-traumatic stress disorder | 1.64e-03 | 202 | 182 | 6 | EFO_0001358 | |
| Disease | interventricular septum thickness | 1.65e-03 | 10 | 182 | 2 | EFO_0009287 | |
| Disease | Cardiomegaly | 1.68e-03 | 82 | 182 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.68e-03 | 82 | 182 | 4 | C1383860 | |
| Disease | Internal Carotid Artery Diseases | 2.01e-03 | 11 | 182 | 2 | C0750986 | |
| Disease | Arterial Diseases, Common Carotid | 2.01e-03 | 11 | 182 | 2 | C0750987 | |
| Disease | Carotid Atherosclerosis | 2.01e-03 | 11 | 182 | 2 | C0577631 | |
| Disease | Adrenal Gland Neoplasms | 2.01e-03 | 11 | 182 | 2 | C0001624 | |
| Disease | External Carotid Artery Diseases | 2.01e-03 | 11 | 182 | 2 | C0600178 | |
| Disease | Carotid Artery Diseases | 2.01e-03 | 11 | 182 | 2 | C0007273 | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 2.01e-03 | 11 | 182 | 2 | OBA_2045176 | |
| Disease | Adrenal Cancer | 2.01e-03 | 11 | 182 | 2 | C0750887 | |
| Disease | complement factor H-related protein 5 measurement | 2.22e-03 | 42 | 182 | 3 | EFO_0008098 | |
| Disease | obesity (implicated_via_orthology) | 2.24e-03 | 215 | 182 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 2.40e-03 | 12 | 182 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.40e-03 | 12 | 182 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.40e-03 | 12 | 182 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | focal segmental glomerulosclerosis (biomarker_via_orthology) | 2.40e-03 | 12 | 182 | 2 | DOID:1312 (biomarker_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.96e-03 | 157 | 182 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | nephroblastoma (is_implicated_in) | 3.28e-03 | 14 | 182 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 3.28e-03 | 14 | 182 | 2 | DOID:3969 (is_marker_for) | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 3.28e-03 | 14 | 182 | 2 | DOID:10873 (is_marker_for) | |
| Disease | red blood cell density measurement | PPP1R21 KALRN MYO9A DNAH2 ATP8B2 ADRA1B RORA KIF4B EIF2AK4 TRAF3IP3 KLHL8 ZRANB1 VPS13B | 3.32e-03 | 880 | 182 | 13 | EFO_0007978 |
| Disease | myocardial infarction (is_implicated_in) | 3.34e-03 | 99 | 182 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | telomere length | 3.41e-03 | 313 | 182 | 7 | EFO_0004505 | |
| Disease | Familial Alzheimer Disease (FAD) | 3.47e-03 | 100 | 182 | 4 | C0276496 | |
| Disease | Alzheimer's Disease | 3.59e-03 | 101 | 182 | 4 | C0002395 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 3.77e-03 | 15 | 182 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | hepatoblastoma (is_marker_for) | 3.77e-03 | 15 | 182 | 2 | DOID:687 (is_marker_for) | |
| Disease | Liver Cirrhosis | 3.85e-03 | 103 | 182 | 4 | C0023890 | |
| Disease | TPE interval measurement | 4.09e-03 | 52 | 182 | 3 | EFO_0004644 | |
| Disease | Fibrosis, Liver | 4.12e-03 | 105 | 182 | 4 | C0239946 | |
| Disease | Rolandic epilepsy | 4.29e-03 | 16 | 182 | 2 | Orphanet_1945 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 4.29e-03 | 16 | 182 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | Hypotension | 4.31e-03 | 53 | 182 | 3 | C0020649 | |
| Disease | lower face morphology measurement | 4.71e-03 | 109 | 182 | 4 | EFO_0010948 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 4.84e-03 | 17 | 182 | 2 | OBA_2045173 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 4.84e-03 | 17 | 182 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | vascular endothelial growth factor measurement | 5.03e-03 | 56 | 182 | 3 | EFO_0004762 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 5.29e-03 | 57 | 182 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_marker_for) | 5.36e-03 | 257 | 182 | 6 | DOID:10652 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.41e-03 | 181 | 182 | 5 | DOID:684 (is_implicated_in) | |
| Disease | sinusitis (is_marker_for) | 5.42e-03 | 18 | 182 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | Adrenocortical carcinoma | 5.42e-03 | 18 | 182 | 2 | C0206686 | |
| Disease | Malignant neoplasm of endometrium | 5.42e-03 | 18 | 182 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 5.42e-03 | 18 | 182 | 2 | C0346191 | |
| Disease | Hemangiosarcoma | 5.42e-03 | 18 | 182 | 2 | C0018923 | |
| Disease | disease free survival | 5.42e-03 | 18 | 182 | 2 | EFO_0000409 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 5.55e-03 | 58 | 182 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | kidney failure (biomarker_via_orthology) | 6.04e-03 | 19 | 182 | 2 | DOID:1074 (biomarker_via_orthology) | |
| Disease | hydrocephalus (implicated_via_orthology) | 6.04e-03 | 19 | 182 | 2 | DOID:10908 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEKHEHILLFLLNNS | 1151 | Q9BXT4 | |
| EALRDLLNNHILKSA | 301 | Q15582 | |
| TLRLFHTETLKHLQD | 1131 | O15013 | |
| HEKLSNLAQIAELSL | 2991 | Q96N23 | |
| LKNSIRSLDALHNIT | 631 | Q96JP9 | |
| LRSSHNELLNAEIKH | 41 | Q92870 | |
| LQLKAHLDEARTLLH | 396 | Q5VTR2 | |
| SLANLHQKSSEIEIL | 1561 | Q9P2K8 | |
| HLNLDETTKLLQDLH | 521 | Q9H8M2 | |
| LTLLQKQHALDLDIT | 431 | P59827 | |
| HSANINLHRKLLTKE | 881 | Q6ZN30 | |
| SSHNQLLLLLHTDRS | 346 | Q5VXM1 | |
| LELQLLEHSLSTNKL | 156 | O15123 | |
| LTLRIHSKNFHEDTL | 251 | P35368 | |
| LLTRHKLLSAEFLEQ | 191 | Q9Y376 | |
| KSLHDNLRSQTLIDL | 196 | O75879 | |
| SLNHKLDSHAELLDA | 86 | Q15027 | |
| AHDLHLSSLQLAKKA | 406 | Q92624 | |
| QLKNLSHLQTLNLSH | 391 | Q99467 | |
| FLLLLSLQEKEHASR | 206 | Q5VUD6 | |
| SHTLLLHQKEINDLL | 256 | Q8ND07 | |
| KLENSLLDHRNKTIH | 246 | P23280 | |
| HSRLTEKLLEATHNN | 221 | Q8TCP9 | |
| LAANSLLNKLIHQSL | 61 | Q9UHL0 | |
| LLNKLIHQSLVESSH | 66 | Q9UHL0 | |
| LHQLQLAATLKEDSI | 101 | Q9BUB4 | |
| LHTELNLQKLSNDRI | 396 | P01019 | |
| LDRLHHSTQELLNTT | 586 | P98198 | |
| TRSSLKHLNHQLQKL | 426 | Q9UFE4 | |
| LLSTAAQDLIHAELK | 346 | Q9H4I0 | |
| IFNKDLLSTLHLLVA | 131 | Q9HBI0 | |
| EKSHQVLAQLLDTLL | 121 | Q96HW7 | |
| RLLHKSIQNSLLGHS | 136 | Q96AZ6 | |
| AEDTITALLHNNRKL | 591 | Q14571 | |
| TALLHNNRKLLEKHI | 596 | Q14571 | |
| AEDTITALLHNNRKL | 591 | Q14573 | |
| TALLHNNRKLLEKHI | 596 | Q14573 | |
| LQKTLDRETQSAHHL | 196 | Q9Y5F8 | |
| KLETLSLNNNHLREL | 86 | Q8N9N7 | |
| LNGHLTKLATLNIHD | 1181 | Q9H1A4 | |
| HLSELLKRTALHGES | 46 | O43929 | |
| ITTLHNLLLHQEGAK | 256 | P35222 | |
| TFEALKHLASLLLHN | 371 | Q9Y4B6 | |
| SLNALTHSSRLKLHL | 26 | Q15058 | |
| RLHFHNLVKGLTDLS | 126 | O00567 | |
| HFSSDLKDLLRNLLQ | 261 | P17612 | |
| RHSLHLTALVQLVKE | 56 | A5PL33 | |
| LSALSREQTHKLELQ | 556 | Q6DN14 | |
| QDAKHRLTLLSAQSL | 926 | Q16706 | |
| AEDTITALLHNNRKL | 591 | Q14643 | |
| TALLHNNRKLLEKHI | 596 | Q14643 | |
| QKLSELDLTFNHLSR | 311 | Q6UXM1 | |
| LHSLVKLDLTDNQLT | 421 | Q9HBX8 | |
| LTFNLRHESAKADLL | 861 | Q9NS40 | |
| LKNLHLNSHVKETTR | 296 | Q9Y2Z2 | |
| LSLHSKLNATADILR | 131 | P15018 | |
| TNDLSFIHLTKHREL | 661 | Q9P266 | |
| AVLKALNATLHSNLL | 16 | Q9Y6H6 | |
| SLSKLLEELSHQLLQ | 641 | Q14164 | |
| HKHSRLAEVLQLGSD | 176 | Q8NCM2 | |
| LSHLQQDSLKLRDSL | 146 | Q9NY93 | |
| NLNLREIDHTKSLTD | 1316 | Q5CZC0 | |
| QKTLEHLQLSHDQLL | 471 | P52789 | |
| SADDLIHLQRAKAIL | 346 | Q5T2Q4 | |
| LHRDSHITNLKGLNL | 481 | P57737 | |
| RHSHALVSLSFLKNL | 391 | P08069 | |
| SLSHLKSLDLSHNLI | 96 | O14498 | |
| QHLENSLSAETRIKL | 566 | Q8N5G2 | |
| DQILRHSLLLHSKVS | 136 | Q3V5L5 | |
| DKLLGELHTLRDQHL | 411 | Q15154 | |
| QHLHKLLSSSDLNIE | 211 | Q9P2G9 | |
| LHQTLEALARDLTKL | 516 | Q9BUK6 | |
| HSAESQILKHLLKNL | 31 | P40261 | |
| ITSLLDKLHSTRQHL | 281 | O60229 | |
| THLILHRDLKTQNIL | 121 | Q86SG6 | |
| SSALIKAQELHALTH | 586 | P63132 | |
| TLHGLEQEHLRKSLA | 501 | Q86UK5 | |
| KLVSLASEVQDLHLA | 111 | Q96N66 | |
| LSTDDLNSLIAHAHR | 396 | Q16891 | |
| LKQELAIHDSLTNRT | 366 | Q9HAQ2 | |
| DNARLAHLILSLEAK | 416 | Q8TE49 | |
| AHLILSLEAKLNLLH | 421 | Q8TE49 | |
| QLLDTKDQSHDLGLH | 1121 | Q13219 | |
| QLQLKTLHEDLSGRL | 201 | Q6ZMI0 | |
| LRKQLLEHSELAFHT | 526 | Q6NUT2 | |
| EQELHSLLASLHTLL | 261 | Q8IZL8 | |
| ELHHTLKNLSLKLDD | 301 | Q969R2 | |
| SSALIKAQELHALTH | 586 | P63135 | |
| SSALIKAQELHALTH | 586 | Q9BXR3 | |
| VNDLLFLKVTSQLHH | 666 | Q8ND30 | |
| DLRNLKLKLHTFESH | 301 | Q16576 | |
| SLLAHLLQSKSELSH | 126 | Q8TEZ7 | |
| LLLKTHQLSLDAFLV | 331 | Q5JVF3 | |
| LLATNRDKEFHSHLT | 1036 | Q66GS9 | |
| KHLEELRASHTSLQA | 331 | Q567U6 | |
| LNTLVQKLHDFLAHS | 11 | P46100 | |
| LSLTERSQIAHALKL | 286 | Q14549 | |
| SEHKLQTKTLNTLHL | 671 | Q9Y2F5 | |
| HFSSDLKDLLRNLLQ | 261 | P22694 | |
| SLVHIINLLQDSKFH | 641 | Q8N1I0 | |
| ELHSTATQLAADLLK | 396 | Q9UBT7 | |
| DLHLSDVFLKALNHL | 331 | P13671 | |
| DLRLSLHLQDQDSVK | 776 | Q6P158 | |
| LSALSDLHAHKLRVD | 81 | P69905 | |
| LSLQEEKTRVSQHHL | 401 | Q8IYE1 | |
| AHRLKNQSSLLHKTL | 176 | Q86WJ1 | |
| DLSHQERLQSKSLHL | 66 | Q9H410 | |
| TLQSEHDTLLERHNK | 1381 | Q8IWJ2 | |
| IHSNVHSDRLLELKS | 2446 | Q5VT06 | |
| NSALDHALRTATILK | 796 | Q5T1N1 | |
| ILHRDLKTSNLLLSH | 546 | Q9UQ88 | |
| LNLLHTELAKQLADT | 96 | Q8NEU8 | |
| LLSRHLKQLLSDHEL | 896 | Q6IQ26 | |
| HSSALERLETKLHLL | 86 | Q8IV03 | |
| DTTTRHLLAAKVLNL | 581 | Q6UXX5 | |
| QAKLSEHRHKLLQEL | 591 | Q2VIQ3 | |
| SRALLHSDEHQLLTN | 96 | Q86W47 | |
| LHNRKVEHEALGSSL | 226 | Q9H9L4 | |
| SLQKALHHLSRLRDL | 346 | Q8IYD9 | |
| SRLHIEALLHGNITK | 721 | P14735 | |
| ISLKNNLDHLLASLL | 386 | Q9H583 | |
| LHLKDLLHLDTALRQ | 216 | P57679 | |
| LTSHLESKALEIQLN | 6416 | Q8NDH2 | |
| ADTFLNLTLKHLHLL | 191 | Q6ZMB0 | |
| HHVISQLQDKRLSLS | 926 | Q9C0D2 | |
| LLDDVQLVNTLHTSK | 3566 | Q9P225 | |
| LESLLIIHDANSRLK | 3521 | Q9NZJ4 | |
| SLTLQQLKALLNHLD | 56 | Q15043 | |
| EKRVIQLHLQHSSLL | 1621 | Q6ZTR5 | |
| HHLSQITEAALALKL | 746 | O75923 | |
| SVLKDLFLEHAHNLA | 116 | P53567 | |
| HLKGIDLQTIHSREL | 226 | Q8IZK6 | |
| NRIATKASHLLETLL | 396 | Q03701 | |
| QHLAELLLAHTDLKS | 181 | Q6ZQY2 | |
| LLTLHQHLDLSSSEK | 246 | Q9UKS6 | |
| GKLQELHRLLQSLES | 206 | Q9BZF2 | |
| THIHKEELELRNQSL | 71 | O14829 | |
| DTLLSNAKHLEILFT | 706 | O15397 | |
| LTLSHLAAVAHKTLQ | 526 | Q5T160 | |
| DTLPLSKNADHLLHL | 371 | Q969X6 | |
| LSHEQKLSQSLEIAL | 421 | O94941 | |
| AADLLLHSKASNLLL | 206 | Q92673 | |
| ISHLSSLIAQLEEKQ | 226 | P14373 | |
| SADTLAHHNDIALLK | 266 | P00749 | |
| DNLALIHAARDTLKL | 321 | Q2YD98 | |
| IKHLHESLLQQLQDS | 2226 | Q8WXH0 | |
| LLVDLKATVLNLHQH | 4056 | Q8WXH0 | |
| LSLNKKIDHELHRLQ | 4926 | Q8WXH0 | |
| VHIHQESALAKLLLT | 21 | Q96HP8 | |
| PTHLDLSALHNVLNK | 1086 | Q6T4R5 | |
| ALDRQTATQLLKLAH | 86 | P62424 | |
| LTHLNEASVLHTLKR | 111 | Q9Y2K3 | |
| LQRELQHEKDTSSLL | 561 | Q96T51 | |
| DLNALHKTTKSQRHL | 86 | P04279 | |
| SQIDRDLHKLSLLAQ | 956 | Q7Z333 | |
| LKTDSLQRLHATHNL | 1061 | Q149N8 | |
| QKSILRDALSDLALH | 301 | P50991 | |
| FDLSVLKLHHSLQQS | 46 | Q9UHV2 | |
| FHRLSEENTLLKNDL | 1086 | Q9Y2I6 | |
| ESTQALLEHLKAHSR | 166 | Q9UPG8 | |
| VRHLLTDLQDHLAKD | 306 | Q6ZS11 | |
| FLSAHKSEQLLRLHK | 5081 | Q63HN8 | |
| HRELESQLHVLQSKL | 336 | Q9Y228 | |
| EALSQHLQSSLHKEK | 3411 | Q86UP3 | |
| KLLDQLHNSLRIDLS | 1481 | Q8NB66 | |
| QHLDLLVRDSSHPNK | 311 | Q9ULX5 | |
| NLEKHQSHLQAKSLL | 171 | P82933 | |
| LELNSSLEFKLHRLH | 186 | Q96G75 | |
| AELEHLAQNISKSHL | 271 | P35398 | |
| HLLNTKLEHVNRDLS | 236 | Q8NDV3 | |
| LILADLHSADQLKTQ | 306 | O43791 | |
| SLENHLAKTHRSLLL | 221 | Q5SVQ8 | |
| RLNELLKEHSSTANI | 1151 | P55011 | |
| SSALIKAQELHALTH | 586 | P10266 | |
| IRSHLQDLKDITHNI | 291 | Q8IYM1 | |
| SSALIKAQELHALTH | 586 | P63133 | |
| LHQLTKLRFLQTEDS | 81 | Q8N5L8 | |
| SSALIKAQELHALTH | 586 | Q9UQG0 | |
| NEHILKLDQATLSLA | 216 | P78562 | |
| SLLTLLNRHKNIHTG | 231 | O75290 | |
| ELKVLRLHSNSLQHV | 291 | Q9NYK1 | |
| SLHLFLQSHLNSEDI | 116 | Q9Y5X0 | |
| LHVVKLLASALSAND | 356 | Q9UPN7 | |
| DSHASLRDSLLTHIQ | 81 | Q9Y5L0 | |
| LRDSLLTHIQNLKDL | 86 | Q9Y5L0 | |
| DPHVKTNLLLQAHLS | 1886 | O75643 | |
| IHHLLLSLQKLREDF | 716 | P86452 | |
| DLTHHKASAELLRLT | 3401 | Q7Z7G8 | |
| IAHLRKVISEHLTNL | 1171 | Q6R2W3 | |
| ESLHLEDNALKVLHN | 261 | Q13641 | |
| SFQTHLKLHLELLLR | 646 | Q2M1K9 | |
| TLILRQNHLASLEKT | 391 | O60603 | |
| RELSISKHLAQNLID | 1266 | Q96QT4 | |
| DKDLSRNSLLHIHQR | 336 | Q9UL59 | |
| DSERKLLHVHFLSAQ | 621 | Q9UGI0 | |
| HSLRLLLEEQLSNKD | 531 | A6NCI4 | |
| KIQALESRSHHLLGL | 581 | Q9BYX2 | |
| LSKDEQLLHLSSQLE | 2811 | Q14789 | |
| HAVFSLLSLQELDLK | 606 | Q8TDW0 | |
| ENLHELDLSNSKLHA | 726 | Q86W25 | |
| SLTHLNLSKNSLRDE | 896 | Q86W25 | |
| HALLNSKDLEHNTKT | 516 | B2RTY4 | |
| HSLSHKEQLLQEFRE | 441 | Q5VU43 | |
| HLTVLTSKRNQLHDE | 411 | P16519 |